ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $826,000 | +35.2% | 240,008 | -1.0% | 0.00% | +33.3% |
| Q4 2020 | $611,000 | +14.4% | 242,428 | -4.2% | 0.00% | +50.0% |
| Q3 2020 | $534,000 | -1.3% | 253,128 | +4.8% | 0.00% | -33.3% |
| Q2 2020 | $541,000 | +1402.8% | 241,475 | +2294.6% | 0.00% | – |
| Q3 2019 | $36,000 | +5.9% | 10,084 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | -85.4% | 10,084 | -88.2% | 0.00% | -100.0% |
| Q1 2019 | $233,000 | -21.3% | 85,523 | -19.6% | 0.00% | -50.0% |
| Q4 2018 | $296,000 | -33.2% | 106,383 | -1.0% | 0.00% | 0.0% |
| Q3 2018 | $443,000 | +10.8% | 107,483 | +39.4% | 0.00% | 0.0% |
| Q2 2018 | $400,000 | – | 77,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |